Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Startups channel feed
Pfizer partners with two more Flagship biotechs on obesity, cancer
5 months ago
Deals
Pharma
Former NCI director teams up with serial entrepreneur for $70M VC fund targeting 'super-early' science
5 months ago
Financing
Atlas Venture targets $450M for 14th biotech fund, the same size as its 2022 raise
5 months ago
Financing
Novartis strikes radiopharma deal with Ratio worth up to $745M
5 months ago
Deals
Pharma
Exclusive: Athena Countouriotis' Avenzo taps Shanghai biotech for ADC, adds new funds
5 months ago
Deals
China
Scottish biotech debuts with ‘Trojan horse’ platform for cancer
5 months ago
R&D
Exclusive: Ascidian CEO Michael Ehlers leaves Apple Tree Partners for MPM BioImpact
5 months ago
People
Metsera raises $215M for studies of GLP-1 and amylin obesity drugs
5 months ago
Financing
Exclusive: Flagship names two CEO-partners to lead Valo Health, Apriori Bio
5 months ago
People
Alentis nabs $181M to broaden Claudin's scope in ADCs
5 months ago
Financing
Roche teams with Flare Therapeutics on transcription factors
5 months ago
Deals
Maze's ALS spinout Trace Neuroscience raises $101M for ALS and neuro work
5 months ago
Financing
GSK snags Parkinson's drug from Flagship startup Vesalius
5 months ago
Deals
Pharma
Yorvipath’s approval showcases biopharma’s interest in rare endocrine disorder
5 months ago
R&D
In Focus
Stephen Squinto's JPM life sciences team is raising a new fund for later-stage companies
6 months ago
Financing
Joe Jimenez's latest Aditum company lines up T cell engager from China
6 months ago
Deals
China
‘We’re good’ on weight loss: Biopharmas turn to muscle with new obesity drugs
6 months ago
R&D
Pharma
Cerebral to pay nearly $3.7M over controlled substance prescribing practices
6 months ago
Pharma
Health Tech
Why hospitals have been slow to adopt AI for medical care
6 months ago
AI
Health Tech
Q&A: Jade CEO talks about reverse merger and IgAN drugs
6 months ago
Deals
Evommune raises $115M for I&I pipeline and prepares for Phase 2 results
6 months ago
Financing
AbbVie adds to T cell engager momentum, with EvolveImmune pact starting at $65M
6 months ago
Deals
Pharma
Another Paragon offshoot inks reverse merger as Jade takes Aerovate’s place
6 months ago
Deals
Blue Earth Therapeutics snags $76M for both alpha and beta radiotherapies
6 months ago
Financing
First page
Previous page
5
6
7
8
9
10
11
Next page
Last page
